Associations of Angiotensin Targeting Antihypertensive Drugs with Mortality and Hospitalization in Primary Care Patients with Dementia

Research output: Contribution to journalArticle (Academic Journal)peer-review

27 Citations (Scopus)

Abstract

We investigated whether angiotensin II receptor blockers and angiotensin converting enzyme inhibitors were associated with risk of mortality or inpatient hospitalization for patients with dementia compared to other antihypertensive medications. We extracted a clinical cohort of 6,290 patients with dementia from the United Kingdom General Practice Research Database, prescribed antihypertensive medication at diagnosis of dementia with around 10 years follow-up. Using survival analysis we estimated associations of exposure to antihypertensive medication with subsequent hospitalization and mortality risk, stratified by dementia type (Alzheimer's disease, vascular and other dementias). Angiotensin converting enzyme inhibitors (but not angiotensin II receptor blockers) were associated with an increased risk of mortality in patients with Alzheimer's disease (adjusted hazard ratio: 1.19; 95% CI 1.07, 1.33, p = 0.002), but no convincing evidence of increased hospitalization. Angiotensin II receptor blockers were inversely associated with hospitalization for any form of dementia, but after adjustment for covariates, these associations became consistent with chance. Further evidence is required to either support or refute the observation that exposure to angiotensin converting enzyme inhibitors in patients with dementia is associated with increased mortality.

Original languageEnglish
Pages (from-to)999-1008
Number of pages10
JournalJournal of Alzheimer's Disease
Volume33
Issue number4
DOIs
Publication statusPublished - 2013

Research Groups and Themes

  • Cerebrovascular and Dementia Research Group

Keywords

  • hospitalization
  • SYSTEM
  • Alzheimer's disease
  • dementia
  • CONVERTING ENZYME
  • VASCULAR DEMENTIA
  • A-BETA
  • vascular dementia
  • ALZHEIMERS-DISEASE
  • AMYLOID BETA-PROTEIN
  • PEPTIDE
  • RANDOMIZED CLINICAL-TRIAL
  • COGNITIVE DECLINE
  • BRAIN
  • angiotensin
  • mortality
  • amyloid

Fingerprint

Dive into the research topics of 'Associations of Angiotensin Targeting Antihypertensive Drugs with Mortality and Hospitalization in Primary Care Patients with Dementia'. Together they form a unique fingerprint.

Cite this